Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1). (Q39849940)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

title

Construction and cellular immune response induction of HA-based alphavirus replicon vaccines against human-avian influenza (H5N1) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

author name string

Shi-gui Yang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Jian-er Wo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Min-wei Li

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Fen-fang Mi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Cheng-bo Yu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Guo-liang Lv

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Hai-feng Lu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Bao-hong Wang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Hanping Zhu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

Lan-Juan Li

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

language of work or name

English

0 references

publication date

29 May 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

page(s)

7451-7458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

Pre- or post-pandemic influenza vaccine?

28 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Cross-clade protective immunity of H5N1 influenza vaccines in a mouse model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

The relative immunogenicity of DNA vaccines delivered by the intramuscular needle injection, electroporation and gene gun methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Type I Interferons are essential for the efficacy of replicase-based DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Alphavirus vectors and vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

A Semliki Forest virus replicon vectored DNA vaccine expressing the E2 glycoprotein of classical swine fever virus protects pigs from lethal challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Vaccination with a DNA vaccine encoding herpes simplex virus type 1 VP22 linked to antigen generates long-term antigen-specific CD8-positive memory T cells and protective immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Computational analysis of proteome of H5N1 avian influenza virus to define T cell epitopes with vaccine potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Engineering an intracellular pathway for major histocompatibility complex class II presentation of antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Development of effective vaccines against pandemic influenza.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Confronting the avian influenza threat: vaccine development for a potential pandemic.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Characterization of avian H5N1 influenza viruses from poultry in Hong Kong

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Potential DNA vaccine integration into host cell genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Cell-mediated protection in influenza infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Antibodies and CD4(+) T-cells mediate cross-protection against H5N1 influenza virus infection in mice after vaccination with a low pathogenic H5N2 strain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Development and preclinical evaluation of an alphavirus replicon vaccine for influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Cancer therapy using a self-replicating RNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

A sindbis virus replicon-based DNA vaccine encoding the rabies virus glycoprotein elicits immune responses and complete protection in mice from lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Alphavirus vectors for gene expression and vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

VP22 enhances antibody responses from DNA vaccines but not by intercellular spread.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Emerging respiratory viruses: challenges and vaccine strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Vaccines for pandemic influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.05.014

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2009.05.014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19450640%20AND%20SRC:MED&resulttype=core&format=json

28 January 2020

1 reference